| Code | 30124 | ||||||||||
| MA number | 20/0255/07-S | ||||||||||
| Product Form: | sol inj 20x4 ml/8 mg (amp.LDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | B.Braun Melsungen AG, Germany | ||||||||||
| Therapeutic Class: | 20 - ANTIEMETICA, ANTIVERTIGINOSA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 16.07.2007 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Ondansetron B. Braun 2 mg_ml injekčný roztok_06_2022.pdf
|
| SPC: |
SPC_Ondansetron B. Braun 2 mg_ml injekčný roztok_06_2022.pdf
|
| Safety feature | Yes |
| Data update: | 26.02.2019 |
